Award Data

The purpose of the continuation of this Direct-to-Phase II effort is to develop a field-expedient, antimicrobial, hydration-providing wound dressing for acute care of large burn wounds.

One of the most important infectious diseases affecting the health of military recruits is adenovirus, which causes acute outbreaks of respiratory disease in military facilities incapacitating personnel, burdening hospitals, disrupting military operations and increasing medical costs. We propose to continue the development of a new generation of adenovirus vaccines based on adenovirus-like particl ...

Initially, our technology and partnerships enable the preservation of good, but otherwise untransplanted, extended criteria donor livers as on‐demand, off‐the‐shelf, back‐up organs to save both civilian and service members patients lives27–32 where there are no options than often near certain death, and hence the FDA path also is attractive (see Transition Pla ...

The Phase II Technical Objectives align with the project goals of developing an outdoor device for spatial protection in a defined, limited outdoor area. While existing work has proven out technology which is effective in indoor areas, the work has not b

This PHASE II two-year proposal is designed to expand upon the knowledge gained already in the PHASE I research regarding the development of rapid bioresorbable glasses to bring us to the making of prototype stents which would be ready for testing in animals and humans. Motivated by the success of PHASE I research, wherein several bioresorbable glasses in the Na2O-K2O-CaO-B2O3-P2O5 have been devel ...

1. Produce AdVLP 55 to address the ongoing epidemic of Adenovirus type 55 causing severe pulmonary infections and death in Asia. 2. Establish analytical methods to monitor in-process production control, characterize the final vaccine product, conduct Ad

Warfighters increasingly rely on mobile devices for voice communication, access to information, and execution of apps that aid them in their tasks. However, untrustworthy applications and risky online behaviors can compromise the mobile device. To be secu

VitaMe Technologies Inc. (doing business as “VitaScan”) and Cornell University will develop the “Iron.Scan” - a point-of-care system for iron deficiency and anemia diagnosis in about 10 minutes from a finger stick of blood. The system comprises of (1) an

We are developing a physiological monitoring tool, PV[O]H, to simultaneously and continuously record hematocrit and vascular volume. The Phase I SBIR established the feasibility of producing an Army useful PV[O]H. Specific Phase II objectives are 1. Complete manufacture of 10 portable units, 2. Finalize FDA discussions to develop the device as a Medical Device Development Tool (MDDT), 3. Finalize/ ...

Hypres is pleased to submit this proposal to continue its Phase II SBIR program and complete the development of a combat-area portable digital MRI (Magnetic Resonance Imaging) system capable of high-resolution Traumatic Brain Injury (TBI) diagnosis in field hospitals. This sequential Phase IIc SBIR program will produce and demonstrate a near production ready state-of-the-art portable MRI system at ...